Prosecution Insights
Last updated: August 17, 2026

Examiner: STEPHENS, AMELIA CAROLE

Tech Center 1600 • Art Units: 1644 1645 1675

This examiner grants 80% of resolved cases

Performance Statistics

80.0%
Allow Rate
+20.0% vs TC avg
34
Total Applications
+50.0%
Interview Lift
1017
Avg Prosecution Days
Based on 5 resolved cases, 2023–2026

Rejection Statute Breakdown

7.8%
§101 Eligibility
22.5%
§102 Novelty
25.6%
§103 Obviousness
25.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18634194 METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY Non-Final OA Mayo Foundation for Medical Education and Research
18290730 DE-CLUSTERING INHIBITORS OF PTPRA Non-Final OA The Regents of the University of California
18500684 MONOCLONAL ANTIBODIES AGAINST SARS-COV-2 AND VARIANTS Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
18804650 MODULAR BIOSENSOR FOR RECEPTOR TYROSINE KINASE ACTIVITY Non-Final OA The Trustees of Princeton University
18564378 PHARMACEUTICAL COMPOSITION FOR TREATING BRAIN DISEASES COMPRISING ANTIBODY SPECIFICALLY BINDING TO ASM PROTEIN AS ACTIVE INGREDIENT Non-Final OA KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month